Bleeding outcomes and factor utilization after switching to an extended half-life product for prophylaxis in haemophilia A in Austria
Sign Up to like & getrecommendations! Published in 2021 at "Scientific Reports"
DOI: 10.1038/s41598-021-92245-5
Abstract: To prevent bleeding in severe haemophilia A [SHA, defined as factor VIII (FVIII) activity  read more here.
Keywords: extended half; outcomes factor; prophylaxis; factor utilization ... See more keywords